Productinformation

The active ingredient Cernitin® pollen extract is manufactured in a dedicated plant in Cernelle´s premises in southern Sweden.

The extract is used in tablet products marketed under the brand names Cernitol® (Sweden) and Cernilton® (rest of the world) for symptom treatment of benign prostate hyperplasia (BPH) and chronic prostatitis (CP/CPPS).

Traditionally used for urinary problems caused by benign prostate enlargement, such as frequent urination and nighttime urinary urgency.

Dosage

2-4tabl daily.

In special need 4-6tabl during 3weeks. After 3weeks, 2-4tabl daily.